Recent Executive Summaries (2023-2024)
Past Meeting Reports
- CDDF Multi-stakeholder workshop on Histology Independent Drug Development: Is this future for cancer drugs? (Nov, 2022)- read the report
- CDDF Multi-stakeholder workshop on the Endpoints in Cancer Drug Development, April 2021 – read the report
- CDDF 12th Spring Conference 2021 – read the report
- CDDF 11th Spring Conference 2020 – read the report
- CDDF Multi-stakeholder workshop on the Use of Real-World Data to Optimize Oncology Drug Development and Access, November 2019 – read the report
- CDDF Multi-stakeholder workshop on Involving Patients In Oncology Drug Development, June 2019- read the report
- CDDF Multi-stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy – read the report
- CDDF Multi-stakeholder workshop on Minimal Residual Disease in AML – CLL, Nov 2018 – read the report
- CDDF Multi-stakeholder workshop on Biomarkers and Patients’ Access to Personalized Oncology Drugs in Europe, 2018 – read the report
- CDDF 10th Alpine Conference on Current and Future Challenges of Innovative Oncology Drugs Development, 2018 – read the report
- CDDF Multi-stakeholder workshop on Minimal Residual Disease, 2017 – read the report
- CDDF-ENCA-ITCC-SIOPE 3rd Paediatric Oncology Conference, 2015 – read the report
- 8th CDDF Alpine Conference, 2015 – read the report
- ITOC-2, 2015 – read the report